Drug profile · INN
bictegravir + emtricitabine + tenofovir alafenamide
BIKTARVY
- Patents linked
- 0
- News articles
- 0
Quick answer
bictegravir + emtricitabine + tenofovir alafenamide (BIKTARVY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
INN bictegravir + emtricitabine + tenofovir alafenamide
Brand BIKTARVY
Originator Gilead Sciences Pty Limited
Frequently asked questions
What is bictegravir + emtricitabine + tenofovir alafenamide?
bictegravir + emtricitabine + tenofovir alafenamide (BIKTARVY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for bictegravir + emtricitabine + tenofovir alafenamide?
BIKTARVY is a marketed brand name for bictegravir + emtricitabine + tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.